Human parvovirus B19 infection and antiphospholipid antibodies

被引:40
作者
von Landenberg, Philipp
Lehmann, Hartwig W.
Modrow, Susanne
机构
[1] Univ Mainz, Inst Klin Chem & Laboratiumsmed, D-55131 Mainz, Germany
[2] Univ Giessen, Zentrum Kinderheilkunde, Giessen, Germany
[3] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-8400 Regensburg, Germany
关键词
parvovirus B19 infection; autoimmune reaction; antiphospholipid antibodies;
D O I
10.1016/j.autrev.2006.09.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Erythema infectiosum is the main manifestation of human parvovirus B19 infections. Further B19-related diseases commonly associated with the acute infection are flue-like symptoms, transient aplastic crisis, transient arthralgias, leukopenia and thrombocytopenia, spontaneous abortion and hydrops fetalis in pregnant women. Hepatitis, myocarditis, meningitis, encephalitis as well as pure red cell anemia may occur occasionally. In addition parvovirus B 19 infections have been frequently described as cause or trigger of various forms of autoimmune diseases affecting all blood cell lines, joints, connective tissue, uvea, large and small vessels. Molecular mimicry may be one major contribution to the appearance of autoimmune antibodies, fe. antiphospholipid and antineutrophil cytoplasmic antibodies as well as antinuclear antigens. These mechanisms implicated in the pathogenesis of parvovirus B 19 triggered autoimmune diseases, especially focused on the development of antiphospholipid antibodies will be discussed in this short review. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:278 / 285
页数:8
相关论文
共 37 条
[1]   THE STRUCTURE OF HUMAN PARVOVIRUS-B19 AT 8-ANGSTROM RESOLUTION [J].
AGBANDJE, M ;
KAJIGAYA, S ;
MCKENNA, R ;
YOUNG, NS ;
ROSSMANN, MG .
VIROLOGY, 1994, 203 (01) :106-115
[2]  
ANDERSON MJ, 1983, LANCET, V1, P1378
[3]   EXPERIMENTAL PARVOVIRAL INFECTION IN HUMANS [J].
ANDERSON, MJ ;
HIGGINS, PG ;
DAVIS, LR ;
WILLMAN, JS ;
JONES, SE ;
KIDD, IM ;
PATTISON, JR ;
TYRRELL, DAJ .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) :257-265
[4]   OCCURRENCE OF INFECTION WITH A PARVOVIRUS-LIKE AGENT IN CHILDREN WITH SICKLE-CELL-ANEMIA DURING A 2-YEAR PERIOD [J].
ANDERSON, MJ ;
DAVIS, LR ;
HODGSON, J ;
JONES, SE ;
MURTAZA, L ;
PATTISON, JR ;
STROUD, CE ;
WHITE, JM .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (07) :744-749
[5]   Association of human parvovirus B19 infection with acute meningoencephalitis [J].
Barah, F ;
Vallely, PJ ;
Chiswick, ML ;
Cleator, GM ;
Kerr, JR .
LANCET, 2001, 358 (9283) :729-730
[6]   Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome [J].
Blank, M ;
Krause, I ;
Fridkin, M ;
Keller, N ;
Kopolovic, J ;
Goldberg, I ;
Tobar, A ;
Shoenfeld, Y .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (06) :797-804
[7]   Parvovirus B19 transmission by heat-treated clotting factor concentrates [J].
Blümel, J ;
Schmidt, I ;
Effenberger, W ;
Seitz, H ;
Willkommen, H ;
Brackmann, HH ;
Löwer, J ;
Eis-Hübinger, AM .
TRANSFUSION, 2002, 42 (11) :1473-1481
[8]   Parvovirus B19:: a pathogen responsible for more than hematologic disorders [J].
Bültmann, BD ;
Klingel, K ;
Sotlar, K ;
Bock, CT ;
Kandolf, R .
VIRCHOWS ARCHIV, 2003, 442 (01) :8-17
[9]   ASSOCIATION BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND ARTHRITIS [J].
CASSINOTTI, P ;
BAS, S ;
SIEGL, G ;
VISCHER, TL .
ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (06) :498-500
[10]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027